These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10446059)

  • 1. Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease.
    Assmann G; Cullen P; Jossa F; Lewis B; Mancini M
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1819-24. PubMed ID: 10446059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease.
    Assmann G; Carmena R; Cullen P; Fruchart JC; Jossa F; Lewis B; Mancini M; Paoletti R
    Circulation; 1999 Nov; 100(18):1930-8. PubMed ID: 10545439
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Mancini M; Jossa F
    Ital Heart J; 2000 May; 1(5 Suppl):699-704. PubMed ID: 10834138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.
    Repo T; Tykkyläinen M; Mustonen J; Rissanen TT; Ketonen M; Toivakka M; Laatikainen T
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29641497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Atherosclerosis; 1994 Oct; 110(2):121-61. PubMed ID: 7848365
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Eur Heart J; 1994 Oct; 15(10):1300-31. PubMed ID: 7821306
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.
    Grundy SM; Balady GJ; Criqui MH; Fletcher G; Greenland P; Hiratzka LF; Houston-Miller N; Kris-Etherton P; Krumholz HM; LaRosa J; Ockene IS; Pearson TA; Reed J; Washington R; Smith SC
    Circulation; 1998 May; 97(18):1876-87. PubMed ID: 9603549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educational level and risk profile and risk control in patients with coronary heart disease.
    Bruthans J; Mayer O; De Bacquer D; De Smedt D; Reiner Z; Kotseva K; Cífková R;
    Eur J Prev Cardiol; 2016 May; 23(8):881-90. PubMed ID: 26283652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration and effects of secondary prevention measures in coronary heart disease patients from Serbia according to gender and cardiometabolic risk.
    Tasic I; Lazarevic G; Kostic S; Djordjevic D; Simonovic D; Rihter M; Vulic D; Stefanovic V
    Acta Cardiol; 2010 Aug; 65(4):407-14. PubMed ID: 20821933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap?
    Pasternak RC; Abrams J; Greenland P; Smaha LA; Wilson PW; Houston-Miller N
    J Am Coll Cardiol; 2003 Jun; 41(11):1863-74. PubMed ID: 12798553
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of antioxidative vitamins in primary and secondary prevention of coronary heart disease.
    Biesalski HK
    Int J Vitam Nutr Res; 1999 May; 69(3):179-86. PubMed ID: 10389025
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.
    Gemmell I; Heller RF; Payne K; Edwards R; Roland M; Durrington P
    Qual Saf Health Care; 2006 Oct; 15(5):339-43. PubMed ID: 17074870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for patients. Aspirin for the prevention of heart attacks in people without previous cardiovascular events: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jan; 136(2):I55. PubMed ID: 11928737
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary prevention in 24, 431 patients with coronary heart disease: survey in primary care.
    Brady AJ; Oliver MA; Pittard JB
    BMJ; 2001 Jun; 322(7300):1463. PubMed ID: 11408303
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    J Hypertens; 1998 Oct; 16(10):1407-14. PubMed ID: 9814610
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coronary risk appraisal for primary prevention of coronary heart disease in a community].
    Furuya H; Nagaoka T; Mizushima S; Ishikawa N; Shibata N; Okamato N; Okazaki I
    Nihon Koshu Eisei Zasshi; 2001 Apr; 48(4):276-88. PubMed ID: 11398315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.